NCT07885488
Screening Elderly Adults in Rural Communities for Heart Failure Using an NT-proBNP-Guided Strategy in China (SEARCH-HF)
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Primary Outcome of Phase 1: New-incident heart-failure diagnosis
Timeframe: 6 months after baseline
Primary Outcome of Extension Study: Composite cardiovascular outcome
Timeframe: 18 months after baseline
Secondary (5)
Positive rate of heart failure
GDMT medication utilization rate
Proportion of participants with newly detected asymptomatic heart failure
Health economic evaluation
New-incident heart-failure diagnosis Using different NT-proBNP thresholds
Arms and interventions
Symptom-based heart failure screeningActive comparator
Participants with typical symptoms of heart failure, including dyspnea, chest tightness, fatigue, or lower-extremity edema, will be recommended for NT-proBNP and echocardiography to further evaluate heart failure.
NT-proBNP-guided heart failure screeningExperimental
Participants with an NT-proBNP level of 125 pg/mL or higher will be recommended to undergo further heart failure symptoms and echocardiographic evaluation for heart failure.
Diagnostic tests: Symptom-based heart failure screening, NT-proBNP-guided heart failure screening
Sites
1 site in 1 country
- Hushu Community Health Service CenterNanjing, China